FGF1 and breast cancer: In a humanized breast cancer mouse model, LSD1 inhibition resulted in reduced FLI1 target gene signatures related to angiogenesis (VEGFA, FGF-1, MMP-1, MMP-9), migration, and invasion (PLAU) (Figure 4).